Skip Navigation



Journal of the National Cancer Institute Advance Access published online on June 17, 2009
JNCI Journal of the National Cancer Institute, doi:10.1093/jnci/djp126
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
101/13/964    most recent
djp126v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Giralt, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giralt, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press.

CORRESPONDENCE

Re: Tandem vs Single Autologous Hematopoietic Cell Transplantation for the Treatment of Multiple Myeloma: A Systematic Review and Meta-analysis

Sergio Giralt, David H. Vesole, George Somlo, Amrita Krishnan, Edward Stadtmauer, Philip Mccarthy, Marcelo C. Pasquini;, on behalf of the Blood and Marrow Transplant Clinical Trials Network Multiple Myeloma Working Group

Affiliations of authors: Department of Stem Cell Transplantation and Cellular Therapy (SG), University of Texas, MD Anderson Cancer Center, Houston, TX; Blood and Marrow Transplant Program (DHV), Loyola University, Stritch School of Medicine, Chicago, IL; Department Hematology and Hematopoietic Cell Transplantation (AK) and Department of Medical Oncology and Therapeutics Research (GS), City of Hope Cancer Center, Los Angeles, CA; Department of Medicine, University of Pennsylvania, PA (ES); Bone Marrow Transplant Program, Roswell Park Cancer Institute, Buffalo, NY (PM); Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI (MCP)

Correspondence to: Marcelo C. Pasquini, MD, MS, Center for International Blood and Marrow Transplant Research 9200 W. Wisconsin Ave, CC5500, Milwaukee, WI 53226 (e-mail: mpasquin@mcw.edu).

The first 10% of the full text of this article appears below.

Kumar et al. (1) recently reported results of a meta-analysis of tandem vs single autologous hematopoietic cell transplantation (HCT) for patients with multiple myeloma. The authors should be commended for trying to address an important and topical issue regarding HCT for multiple myeloma. However, we disagree with their conclusions, which we believe . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?